SUMO1P3 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), SUMO1P3 is associated with clinical progression, and it promotes cell migration and invasion by binding and suppressing miR-136, an anti-oncogenic miRNA in human cancers [93].